Fucoxanthin extracted and purified from Vietnamese Sargassum oligocystum Montagne, 1845 exhibits various biological activities. In this study, the ability of fucoxanthin to inhibit acetylcholinesterase (AChE), the antioxidant activities, and the expression of antioxidant enzymes were investigated. Fucoxanthin isolated from Vietnamese S. oligocystum showed no cytotoxic effects; moreover, it exhibited AChE inhibitory activity (with an IC₅₀ value of 130.12 ± 6.65 μg mL⁻¹) and antioxidant activity (with an IC₅₀ value of 3.42 ± 0.15 mg mL⁻¹). At concentrations of 50 and 100 µg mL⁻¹, fucoxanthin provided protection against amyloid β-protein fragment 25–35-induced neurotoxicity in a C6 neuronal cell line, and the survival of C6 cells was higher than 81.01% and 80.98%, respectively, compared to the control group (59%). Moreover, antioxidant enzyme activity and quantitative PCR analysis suggested that the neuroprotective effect of fucoxanthin resulted from regulation of the gene expression of antioxidant enzymes (CAT and GPx) and ER pathways (caspase-3 and Bax), as well as the promotion of expression of genes involved in PI3K/Akt signaling (GSK-3β), autophagy (p62 and ATG5), and the biosynthesis of ACh (VAChT and ChAT). Therefore, fucoxanthin extracted from the seaweed S. oligocystum in Vietnam is a potential feedstock source for the production of health foods that exert neuroprotective effects.

This study investigates the suitability of Spirulina-Ogawa-Terui (SOT) culture media with various nutrition concentrations for the laboratory growth of salt-tolerant Spirulina platensis ST. Among the four saltwater mediums, 25% SOT media (42‰ salinity) demonstrated a satisfactory performance, with maximum absorbance at a wavelength 556 nm reading of 0.76. After 15 cultivation days, the protein, carbohydrate, lipid, phycocyanin, chlorophyll a, and carotenoid contents reached 48.73%, 22.14%, 7.32%, 10.23%, 0.53%, and 0.12% of the dry cell weight (DCW), respectively. The growth of S. platensis ST is influenced by the culture medium with a salinity of 13‰ and 52‰, as well as different nutrient compositions. Transcriptional sequencing revealed that the response of S. platensis ST to salt stress was mainly expressed by regulating the gene expression involved in metabolic pathways such as photosynthesis and signaling transduction. Under nutritional and salt stress, S. platensis ST responds by modulating the gene expression involved in the synthesis of vital molecules, for example, growth regulators and adenosine triphosphate (ATP) producers. In conclusion, this study provides an insight into enhancing the ability of S. platensis to tolerate salt stress. The findings indicate that future efforts in algal-based cultivation research in seawater should focus on increasing the productivity to develop a sustainable industry for biomass production.

Astaxanthin and kaempferol, renowned natural compounds, possess potent antioxidant properties and exhibit remarkable biological activities. However, their poor water solubility, low stability, and limited bioavailability are the primary bottlenecks that restrict their utilization in pharmaceuticals and functional foods. To overcome these drawbacks, this study aims to fabricate astaxanthin/kaempferol co-encapsulated nanoparticles and investigate their synergistic effects on reducing the risk of stress oxidation, chronic inflammation, and lipid accumulation in RAW264.7 and HepG2 cells. The synthesized astaxanthin/kaempferol nanoparticles exhibited well-defined spherical morphology with an average particle diameter ranging from 74 to 120 nm. These nanoparticles demonstrated excellent stability with the remaining astaxanthin content ranging from 82.5% to 92.1% after 6 months of storage at 4 °C. Nanoastaxanthin/kaempferol displayed high dispersibility and stability in aqueous solutions, resulting in a significant enhancement of their bioactivity. In vitro assessments on cell lines revealed that nanoastaxanthin/kaempferol enhanced the inhibition of H₂O₂-induced oxidative stress in HepG2 and LPS-induced NO production in RAW264.7 compared to nanoastaxanthin. Additionally, these nanoparticles reduced the expression of genes involved in inflammation (iNOS, IL-6 and TNF-α). Moreover, hepatocytes treated with nanoastaxanthin/kaempferol showed a reduction in lipid content compared to those treated with nanoastaxanthin, through enhanced regulation of lipid metabolism-related genes. Overall, these findings suggest that the successful fabrication of co-encapsulated nanoparticles containing astaxanthin and kaempferol holds promising therapeutic potential in the treatment of non-alcoholic fatty liver disease.

Background: Haematococcus pluvialis, a green microalga, is a rich source of natural astaxanthin and a potent antioxidant with high commercial value. This study investigates the biological characteristics and potential of H. pluvialis HB isolated from Hoa Binh, Vietnam, for growth and astaxanthin accumulation using a two-phase culture method. Methods: H. pluvialis HB was cultured in a C/RM medium at 25 °C, and morphological characteristics were examined. NMR spectroscopy was used to determine the structure of the astaxanthin, which was extracted using the Soxhlet method. Results: After 22 days, the highest cell density (4.96 × 10⁶ cells mL⁻¹) was achieved under optimized light and ultraviolet conditions. Nutrient deprivation followed by bicarbonate supplementation resulted in a maximal astaxanthin accumulation of 48.8 mg g⁻¹ dry cell weight within two days. The extracted astaxanthin demonstrated potent antioxidant activity (IC₅₀: 3.74 mg mL⁻¹) compared to ascorbic acid (IC₅₀: 18.53 µg mL⁻¹) and exhibited strong acetylcholinesterase inhibition (IC₅₀: 297.99 µg mL⁻¹). It also showed neuroprotective effects against H₂O₂ and amyloid beta-induced neurotoxicity in C6 cells. Conclusions: This study highlights H. pluvialis HB as a promising source for large-scale astaxanthin production with potential applications in neuroprotective health products.

Aurantiochytrium is a heterotrophic marine microalga that has potential industrial applications. The main objectives of this study were to isolate an Aurantiochytrium strain from Sand Cay (Son Ca) Island, Vietnam, optimize its culture conditions, determine its nutritional composition, extract polyunsaturated fatty acids (PUFAs) in the free (FFA) and the alkyl ester (FAAE) forms, and evaluate the antioxidation and neuroprotection properties of the PUFAs. Aurantiochytrium sp. SC145 can be grown stably under laboratory conditions. Its culture conditions were optimized for a dry cell weight (DCW) of 31.18 g/L, with total lipids comprising 25.29%, proteins 7.93%, carbohydrates 15.21%, and carotenoid at 143.67 µg/L of DCW. The FAAEs and FFAs extracted from Aurantiochytrium sp. SC145 were rich in omega 3–6–9 fatty acids (40.73% and 44.00% of total fatty acids, respectively). No acute or subchronic oral toxicity was determined in mice fed with the PUFAs in FFA or FAAE forms at different doses over 90 days. Furthermore, the PUFAs in the FFA or FAAE forms and their main constituents of EPA, DHA, and ALA showed antioxidant and AChE inhibitory properties and neuroprotective activities against damage caused by H₂O₂- and amyloid-ß protein fragment 25–35 (Aβ_25-35)-induced C6 cells. These data suggest that PUFAs extracted from Aurantiochytrium sp. SC145 may be a potential therapeutic target for the treatment of neurodegenerative disorders.